Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice.
Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice.
复制标题
DOI：
10.3389/fpsyg.2021.645246
复制
发表时间：
2021
影响因子：
3.8
通讯作者：
Sabbagh J
中科院分区：
文献类型：
--
作者：
Gorman I;Nielson EM;Molinar A;Cassidy K;Sabbagh J
Psychedelic Harm Reduction and Integration（PHRI）是一种跨理论和跨诊断的临床方法，用于治疗正在使用或考虑在任何情况下使用迷幻药的患者。学术研究和主流媒体对迷幻剂的持续讨论，加上最近执法部门对迷幻剂的优先级降低和对迷幻剂辅助治疗的同情使用批准，使得这种模式非常及时。鉴于迷幻药使用的普遍性，迷幻药的治疗潜力，以及迷幻药所处的独特文化和历史背景，心理健康提供者必须了解使用它们的人的独特动机，经验和需求。PHRI融合了减少伤害心理治疗和迷幻辅助心理治疗的元素，可以应用于短暂和持续的心理治疗互动。PHRI代表了一种转变，即从仅限于迷幻剂使用和基于戒断的成瘾治疗范式的不良结果的评估，转向对患者选择的同情、去污名化接受的立场。考虑评估，准备，并与困难的经验。
Psychedelic Harm Reduction and Integration (PHRI) is a transtheoretical and transdiagnostic clinical approach to working with patients who are using or considering using psychedelics in any context. The ongoing discussion of psychedelics in academic research and mainstream media, coupled with recent law enforcement deprioritization of psychedelics and compassionate use approvals for psychedelic-assisted therapy, make this model exceedingly timely. Given the prevalence of psychedelic use, the therapeutic potential of psychedelics, and the unique cultural and historical context in which psychedelics are placed, it is important that mental health providers have an understanding of the unique motivations, experiences, and needs of people who use them. PHRI incorporates elements of harm reduction psychotherapy and psychedelic-assisted psychotherapy, and can be applied in both brief and ongoing psychotherapy interactions. PHRI represents a shift away from assessment limited to untoward outcomes of psychedelic use and abstinence-based addiction treatment paradigms and toward a stance of compassionate, destigmatizing acceptance of patients' choices. Considerations for assessment, preparation, and working with difficult experiences are presented.
登录
查看更多内容
影响因子：
6.6
作者：
Baeuml, Josef;Froboese, Teresa;Pitschel-Walz, Gabriele
通讯作者：
Pitschel-Walz, Gabriele
影响因子：
4.3
作者：
Barrett, Frederick S.;Johnson, Matthew W.;Griffiths, Roland R.
通讯作者：
Griffiths, Roland R.
影响因子：
5.9
作者：
Conners, GJ;Carroll, KM;Donovan, DM
通讯作者：
Donovan, DM
影响因子：
3.9
作者：
Coppock, Timothy E.;Owen, Jesse J.;Schmidt, Melissa
通讯作者：
Schmidt, Melissa
DOI：
10.1016/b978-0-12-416031-6.00007-4
发表时间：
2014-01-01
期刊：
MINDFULNESS-BASED TREATMENT APPROACHES: CLINICIAN'S GUIDE TO EVIDENCE BASE AND APPLICATIONS, 2ND EDITION
影响因子：
--
作者：
Bowen, Sarah;Chawla, Neha;Witkiewitz, Katie
通讯作者：
Witkiewitz, Katie